Previous 10 | Next 10 |
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections, today announced that data for EDP-938, its oral, once-daily, N-protein inhibitor in development for the treatment of respiratory syncytial v...
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , Se...
2023-09-01 18:33:42 ET More on Airbnb and Blackstone Airbnb: Upgrading To Hold, Headwinds Priced In How To Think About Airbnb Blackstone: Load Up Before It Recovers Its All-Time Highs (Rating Upgrade) Blackstone: Time For A Rating Downgrade Airbnb: Ev...
2023-08-09 15:34:02 ET JP Morgan has downgraded Enanta Pharmaceuticals ( NASDAQ: ENTA ) to neutral, citing extended commercialization timelines for its COVID-19 and RSV treatment candidates. The investment bank said it sees a challenging road ahead for the company's COVID-19 dru...
2023-08-08 16:54:17 ET Jefferies has downgraded Enanta ( NASDAQ: ENTA ) to hold, citing concerns that the company won't be able to find a commercial partner for its COVID-19 treatment EDP-235. The investment bank said it was wary of Enanta's plan not to move EDP-235 into Phase 3...
2023-08-08 14:23:06 ET Shares of Enanta Pharmaceuticals (NASDAQ: ENTA) were down more than 9% as of 11:45 a.m. on Tuesday after the clinical-stage biotech released fiscal third-quarter earnings on Tuesday. The stock is down more than 62% so far this year. Enanta focuses on f...
2023-08-08 10:21:19 ET Gainers: Bright Minds Biosciences ( DRUG ) +62% . Bionomics ( BNOX ) +24% . Novo Nordisk ( NVO ) +18% . Quanterix ( QTRX ) +17% . Tilray Brands ( TLRY ) +18% . Losers: Vistagen Therapeutics ( VTGN ...
2023-08-07 20:42:10 ET Enanta Pharmaceuticals, Inc. (ENTA) Q3 2023 Results Conference Call August 07, 2023 04:30 PM ET Company Participants Jennifer Viera - Investor Relations Jay Luly - President and Chief Executive Officer Paul Mellett - Chief Financial Officer...
2023-08-07 16:02:32 ET Enanta Pharma press release ( NASDAQ: ENTA ): Q3 GAAP EPS of -$1.86 beats by $0.47 . Revenue of $18.89M (-3.0% Y/Y) beats by $2.15M . For further details see: Enanta Pharma GAAP EPS of -$1.86 beats by $0.47, revenue of $18.89M beats...
Reported Positive Topline Data from Phase 1 Study of EDP-323, an L-Protein Inhibitor in Development as an Oral, Once-Daily Treatment for Respiratory Syncytial Virus (RSV); Expect to Initiate Phase 2 Human Challenge Study in Early 4Q 2023. Cash and Marketable Securities Totaled $392.5 ...
News, Short Squeeze, Breakout and More Instantly...
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
NASDAQ Market:
Enanta Pharmaceuticals Inc. Website:
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strate...
2024-05-10 16:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Nuwellis Inc. (NUWE) rose 60.3% to $0.2741 on volume of 66,284,094 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 21.1% to $0.05 on volume of 64,247,106 shares Clearmind Medicine Inc. (CMND) rose 37.6% to $1.61 on volume ...